Huaijun Zhou

1.3k total citations
38 papers, 523 citations indexed

About

Huaijun Zhou is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Huaijun Zhou has authored 38 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 8 papers in Obstetrics and Gynecology. Recurrent topics in Huaijun Zhou's work include Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Huaijun Zhou is often cited by papers focused on Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Huaijun Zhou collaborates with scholars based in China, Switzerland and Tanzania. Huaijun Zhou's co-authors include Xiaofeng Xu, Yali Hu, Jun Wu, Xiangyi Kong, Guijun Yan, Jian Fu, Feifei Guo, Haixiang Sun, Rong‐Rong He and Lijun Ding and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cerebral Cortex.

In The Last Decade

Huaijun Zhou

30 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaijun Zhou China 14 291 242 88 87 62 38 523
Xiujie Sheng China 10 292 1.0× 227 0.9× 61 0.7× 56 0.6× 48 0.8× 24 454
Minyue Tang China 11 302 1.0× 234 1.0× 27 0.3× 48 0.6× 74 1.2× 20 470
Wu-Wen Zhang China 11 295 1.0× 219 0.9× 77 0.9× 42 0.5× 101 1.6× 15 467
Ensong Guo China 12 211 0.7× 122 0.5× 139 1.6× 31 0.4× 81 1.3× 22 467
Xuejie Zhu China 10 194 0.7× 138 0.6× 96 1.1× 33 0.4× 57 0.9× 15 387
Ziba Nariman‐Saleh‐Fam Iran 17 419 1.4× 309 1.3× 59 0.7× 26 0.3× 67 1.1× 39 610
Xiangyang Zeng China 8 225 0.8× 174 0.7× 92 1.0× 101 1.2× 101 1.6× 17 492
Kimberly Malloy United States 9 371 1.3× 97 0.4× 213 2.4× 88 1.0× 44 0.7× 23 565
Shannon MacLaughlan United States 9 177 0.6× 143 0.6× 88 1.0× 34 0.4× 45 0.7× 15 397
Jiangdong Xiang China 10 138 0.5× 115 0.5× 107 1.2× 29 0.3× 71 1.1× 25 371

Countries citing papers authored by Huaijun Zhou

Since Specialization
Citations

This map shows the geographic impact of Huaijun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaijun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaijun Zhou more than expected).

Fields of papers citing papers by Huaijun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaijun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaijun Zhou. The network helps show where Huaijun Zhou may publish in the future.

Co-authorship network of co-authors of Huaijun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huaijun Zhou. A scholar is included among the top collaborators of Huaijun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaijun Zhou. Huaijun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaochang, Dailu Guan, Huaijun Zhou, et al.. (2024). Age-dependent genetic architectures of chicken body weight explored by multidimensional GWAS and molQTL analyses. Journal of genetics and genomics. 51(12). 1423–1434. 8 indexed citations
2.
Li, Zhiwen, et al.. (2024). Uterine smooth muscle tumors of uncertain malignant potential: a 13-year retrospective study. Frontiers in Oncology. 14. 1458968–1458968.
3.
Jiao, Beibei, Ruilin Chen, Si Chen, et al.. (2024). Plant medicine metabolite Yulinzhu treating neurological disorder causing polycystic ovary syndrome: a systematic review and a meta-analysis. Frontiers in Pharmacology. 15. 1458621–1458621.
4.
Wang, Lu, et al.. (2024). The coagulation status in women of endometriosis with stage IV. BMC Women s Health. 24(1). 386–386. 3 indexed citations
6.
Li, Jian, Yan Tong, Ling Zhou, et al.. (2024). Krüppel-like factor 12 decreases progestin sensitivity in endometrial cancer by inhibiting the progesterone receptor signaling pathway. Translational Oncology. 47. 102041–102041. 1 indexed citations
7.
Guo, Feifei, et al.. (2023). Triglyceride‐glucose index (TyG index) and endometrial carcinoma risk: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 164(1). 298–304. 12 indexed citations
8.
Zhu, Yanping, et al.. (2023). A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis. Frontiers in Endocrinology. 14. 1156169–1156169. 4 indexed citations
9.
Wu, Jun, et al.. (2021). Network Pharmacology-Based Study on the Mechanism of Aloe Vera for Treating Cancer. Evidence-based Complementary and Alternative Medicine. 2021. 1–8. 4 indexed citations
10.
Xu, Xiaofeng, et al.. (2021). Surgical outcomes of cesarean scar pregnancy: an 8-year experience at a single institution. Archives of Gynecology and Obstetrics. 303(5). 1223–1233. 12 indexed citations
11.
Kong, Xiangyi, Xiaofeng Xu, Ling Zhou, et al.. (2020). MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2. Molecular Therapy — Methods & Clinical Development. 19. 295–306. 19 indexed citations
12.
Zhang, Zhengyu, Rong Li, Ke Han, et al.. (2019). Recurrence-related Factors of 46 Stage Ⅰ-Ⅱ Endometrial Carcinoma Patients. SHILAP Revista de lepidopterología.
13.
Xu, Xiaofeng, Tao Liu, Jun Wu, et al.. (2019). Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer. Cancer Gene Therapy. 26(11-12). 356–365. 32 indexed citations
14.
Xu, Xiaofeng, Xiangyi Kong, Tao Liu, et al.. (2019). Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway. Gynecologic Oncology. 154(1). 207–217. 25 indexed citations
15.
Li, Zhongxun, Guijun Yan, Fei Yu, et al.. (2019). Transplantation of human endometrial perivascular cells with elevated CYR61 expression induces angiogenesis and promotes repair of a full-thickness uterine injury in rat. Stem Cell Research & Therapy. 10(1). 179–179. 42 indexed citations
16.
Ding, Ling, Xiangyi Kong, Jun Wu, et al.. (2018). Dysregulation of Krüppel-like factor 12 in the development of endometrial cancer. Gynecologic Oncology. 152(1). 177–184. 23 indexed citations
17.
Kong, Xiangyi, Xiaofeng Xu, Feifei Guo, et al.. (2014). Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer. PLoS ONE. 9(3). e90810–e90810. 52 indexed citations
18.
Hu, Yali, et al.. (2013). Two cases of aggressive angiomyxoma of vulva. Chinese Medical Journal. 126(16). 3191–3191. 1 indexed citations
20.
Hu, Yali, Xiaofeng Xu, Rong Li, et al.. (2013). Diagnostic challenges in minimal deviation adenocarcinoma of the uterine cervix: A report of two cases and review of the literature. Molecular and Clinical Oncology. 1(5). 833–838. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026